A European approach to clinical investigator training

A better education and training of clinical investigators and their teams is one of the factors that could foster the development of clinical research in Europe, a key objective of the Innovative Medicines Initiative (IMI). PharmaTrain (an IMI programme on training in medicines development), and Eur...

Full description

Saved in:

Bibliographic Details
Published in:	Frontiers in pharmacology Vol. 4; p. 112
Main Authors:	Boeynaems, Jean-Marie, Canivet, Cindy, Chan, Anthony, Clarke, Mary J, Cornu, Catherine, Daemen, Esther, Demotes, Jacques, Nys, Katelijne De, Hirst, Barry, Hundt, Ferdinand, Kassai, Behrouz, Kerpel-Fronius, Sandor, Kiessig, Lucy, Klech, Heinrich, Kraehenbuhl, Jean-Pierre, Lafolie, Pierre, Lucht, Martin, Niese, Detlef, Pauli-Magnus, Christiane, Peters, Barbara, Schaltenbrand, Ralf, Stockis, Armel, Stykova, Martina, Verheus, Nicolette, Klingmann, Ingrid
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers 01-01-2013 Frontiers Media S.A
Subjects:	Certification clinical investigator Clinical Trials as Topic GCP Life Sciences Medicin och hälsovetenskap Pharmacology training clinical trials as topic clinical investigator training GCP certification
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	A better education and training of clinical investigators and their teams is one of the factors that could foster the development of clinical research in Europe, a key objective of the Innovative Medicines Initiative (IMI). PharmaTrain (an IMI programme on training in medicines development), and European Clinical Research Infrastructures Network (ECRIN) have joined forces to address this issue. An advisory group composed of representatives of universities, pharmaceutical companies and other organisations met four times between June 2011 and July 2012. This resulted in a position paper proposing a strategy to improve and harmonize clinical investigator training in Europe, and including a detailed syllabus and list of learning outcomes. Major recommendations are the establishment of minimal and mutually recognized certification requirement for investigators throughout the EU and the creation of a European platform to provide a suitable course and examination infrastructure.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 PMCID: PMC3766792 Edited by: Jean-Paul Deslypere, Proclin Therapeutic Research Pte Ltd., Singapore This article was submitted to Pharmaceutical Medicine and Outcomes Research, a section of the journal Frontiers in Pharmacology. Reviewed by: Sunita Nair, Capita India Pvt Ltd., India; Domenico Criscuolo, Genovax, Italy; Joao Massud, Trials Consulting, Brazil
ISSN:	1663-9812 1663-9812
DOI:	10.3389/fphar.2013.00112